Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q2 2026 Earnings

14MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.67

-0.57

-0.46

-0.35

Details

Expected EPS

-0.673462

Actual EPS

-0.46

Surprise EPS

0.21

Surprise Percent

+31.7%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.46 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.